Global Tissue Fixative Market Growth 2025-2031
Description
The global Tissue Fixative market size is predicted to grow from US$ 29.6 million in 2025 to US$ 41.3 million in 2031; it is expected to grow at a CAGR of 5.7% from 2025 to 2031.
In histopathology, tissues must first undergo timely and effective fixation to complete subsequent embedding and sectioning. The purpose of tissue fixation is to preserve the inherent shape and structure of tissues and cells, prevent bacterial corrosion and autolysis of tissue cells, preserve intracellular substances, coagulate proteins inside cells, minimize or terminate both endogenous and exogenous enzymatic reactions, and maintain the tissue or cell's material composition similar to that in living conditions. It also hardens the tissue, making it easier to section. For specimens with infectious potential, fixation helps prevent the spread of disease and preserves gross specimens. Lastly, fixation enhances the staining process. Formaldehyde is the most commonly used fixative due to its strong penetration, uniform fixation, minimal tissue shrinkage, and appropriate hardness, making it suitable for fixing the vast majority of tissue samples.
United States market for Tissue Fixative is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Tissue Fixative is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Tissue Fixative is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Tissue Fixative players cover Liaoshiyuan Biomedical Technology, Thermo Fisher Scientific, Leica Biosystems, Servicebio, Saiguo Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Tissue Fixative Industry Forecast” looks at past sales and reviews total world Tissue Fixative sales in 2024, providing a comprehensive analysis by region and market sector of projected Tissue Fixative sales for 2025 through 2031. With Tissue Fixative sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tissue Fixative industry.
This Insight Report provides a comprehensive analysis of the global Tissue Fixative landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tissue Fixative portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tissue Fixative market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tissue Fixative and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tissue Fixative.
This report presents a comprehensive overview, market shares, and growth opportunities of Tissue Fixative market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
DEPC-free
DEPC-containing
Segmentation by Application:
Immunohistochemistry
Immunocytochemistry
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Liaoshiyuan Biomedical Technology
Thermo Fisher Scientific
Leica Biosystems
Servicebio
Saiguo Biotechnology
Boster Biological Technology
Abcam
Leagene
Beyotime
Sangon Biotech
Biosharp
Absin
Wako
Biotium
R&D Systems
Key Questions Addressed in this Report
What is the 10-year outlook for the global Tissue Fixative market?
What factors are driving Tissue Fixative market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tissue Fixative market opportunities vary by end market size?
How does Tissue Fixative break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
In histopathology, tissues must first undergo timely and effective fixation to complete subsequent embedding and sectioning. The purpose of tissue fixation is to preserve the inherent shape and structure of tissues and cells, prevent bacterial corrosion and autolysis of tissue cells, preserve intracellular substances, coagulate proteins inside cells, minimize or terminate both endogenous and exogenous enzymatic reactions, and maintain the tissue or cell's material composition similar to that in living conditions. It also hardens the tissue, making it easier to section. For specimens with infectious potential, fixation helps prevent the spread of disease and preserves gross specimens. Lastly, fixation enhances the staining process. Formaldehyde is the most commonly used fixative due to its strong penetration, uniform fixation, minimal tissue shrinkage, and appropriate hardness, making it suitable for fixing the vast majority of tissue samples.
United States market for Tissue Fixative is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Tissue Fixative is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Tissue Fixative is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Tissue Fixative players cover Liaoshiyuan Biomedical Technology, Thermo Fisher Scientific, Leica Biosystems, Servicebio, Saiguo Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Tissue Fixative Industry Forecast” looks at past sales and reviews total world Tissue Fixative sales in 2024, providing a comprehensive analysis by region and market sector of projected Tissue Fixative sales for 2025 through 2031. With Tissue Fixative sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tissue Fixative industry.
This Insight Report provides a comprehensive analysis of the global Tissue Fixative landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tissue Fixative portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tissue Fixative market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tissue Fixative and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tissue Fixative.
This report presents a comprehensive overview, market shares, and growth opportunities of Tissue Fixative market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
DEPC-free
DEPC-containing
Segmentation by Application:
Immunohistochemistry
Immunocytochemistry
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Liaoshiyuan Biomedical Technology
Thermo Fisher Scientific
Leica Biosystems
Servicebio
Saiguo Biotechnology
Boster Biological Technology
Abcam
Leagene
Beyotime
Sangon Biotech
Biosharp
Absin
Wako
Biotium
R&D Systems
Key Questions Addressed in this Report
What is the 10-year outlook for the global Tissue Fixative market?
What factors are driving Tissue Fixative market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tissue Fixative market opportunities vary by end market size?
How does Tissue Fixative break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
106 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Tissue Fixative by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Tissue Fixative by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
